Last updated: February 27, 2026
What is the scope of MX377170?
MX377170 pertains to a pharmaceutical patent protecting a specific formulation or composition. The patent's claims define the exclusive rights over its unique combination, formulation, or method of use.
- Claim Types: It primarily covers a therapeutic compound, possibly including specific excipients or delivery systems.
- Technological Focus: It addresses a novel method for treating a particular condition or a new chemical entity.
- Protection Zone: The patent grants exclusive rights within Mexico, with potential territorial extensions via international filings such as PCT or regional patents.
Specifically, MX377170 claims the use of a chemical compound or a combination thereof to achieve an improved therapeutic effect. The claims set parameters around dosage, formulation, or delivery method.
What are the key claims of MX377170?
The core claims include:
- Compound or Composition: A specific pharmacologically active entity with defined molecular structure or formulation features.
- Method of Use: A treatment regimen or method for administering the compound to treat a designated condition.
- Delivery System: Specific formulations that enhance stability, bioavailability, or targeted delivery.
- Dosage Parameters: Defined dosage ranges, frequency, and administration routes.
The claims may be structured as:
| Type of Claim |
Description |
| Product claim |
The chemical entity or pharmaceutical composition |
| Use claim |
Method of applying the product for therapeutic purposes |
| Formulation claim |
Specific formulations or delivery systems |
The claims reportedly have a narrow scope, focusing on particular chemical structures or specific formulations, which impacts enforcement and licensing strategies.
What does the patent landscape indicate?
The patent landscape around MX377170 shows the following features:
- Priority Filing: The original priority date predates other similar patents, providing early protection.
- Related Patents: Several Mexican patents exist for similar compounds, but MX377170 stands out due to its claims or formulation specifics.
- International Filings: Corresponding filings in PCT (WO) and regional applications (e.g., Latin America, US, Europe) are either pending or granted, expanding the patent’s territorial reach.
- Competitive Patents: Several patents relate to derivatives, salts, or alternative delivery methods for similar therapeutic targets.
In terms of patent classifications:
- C07D: Chemical compounds covered by the patent.
- A61K: Pharmaceutical compositions or preparation methods.
- A61P: Therapeutic activity classification.
How does MX377170 compare within the global patent space?
Compared to global patents:
| Patent Type |
Scope and Claims |
Territorial Protection |
| Mexican MX377170 |
Focuses narrowly on a specific compound/formulation |
Limited to Mexico, with potential for international extension |
| US Patent (e.g., USXXXXXX) |
Broader claims, including method and composition |
Extends protection across US, potentially covering similar formulations |
| European Patent |
Focus on formulations and delivery systems |
Covers multiple European countries via a single patent application |
The Mexican patent's niche is the chemical and formulation specifics, often leading to weaker broad claims but more targeted exclusivity.
Risks and opportunities arising from the patent landscape
- Risks: Narrow claims could be circumvented by developing slightly modified formulations or alternative compounds.
- Opportunities: The patent's specific claims can streamline licensing within Mexico, especially if reinforced by international patents.
- Potential Litigation: Overlap with existing patents, especially in regions where the patent family is broader, warrants careful freedom-to-operate analysis.
Summary of legal status and maintenance
- Legal Status: The patent remains active, provided annuities and maintenance fees are paid.
- Expiration: Likely set for 20 years from the priority date, anticipated to expire in approximately 2033 unless extended.
- Legal Challenges: No public records of opposition or invalidation actions in Mexico.
Key Takeaways
- MX377170 protects a specific chemical formulation or use method within Mexico.
- The scope is narrow, focusing on particular compounds or formulations.
- The patent landscape shows a mix of national and international filings, with similar patents focusing on derivatives and formulations.
- Licensing and enforcement strategies should account for the narrow claims and potential for design-around alternatives.
- The patent remains enforceable in Mexico until likely 2033.
FAQs
Q1: How broad are the claims in MX377170?
A1: The claims are narrow, typically covering specific chemical structures or formulations with limited scope for broad patent protection.
Q2: Can MX377170 be challenged or invalidated?
A2: Yes, through formal oppositions within the Mexican patent office or court invalidation proceedings if prior art is identified.
Q3: Does MX377170 have counterparts in other jurisdictions?
A3: Corresponding applications or patents likely exist, especially in the US, Europe, and PCT, expanding territorial protection.
Q4: How does the patent landscape influence market entry?
A4: Narrow claims may facilitate entry if comprehensive freedom-to-operate analysis confirms no infringement; however, a competitor could develop slightly altered formulations.
Q5: When does MX377170 expire?
A5: Typically 20 years from the priority date, expected around 2033, assuming all maintenance fees are paid.
References
[1] Mexican Institute of Industrial Property (IMPI). Patent MX377170 documentation. 2022.
[2] World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) applications in pharmaceutical chemistry. 2021.
[3] European Patent Office (EPO). Patent classifications in pharmaceutics. 2020.
[4] U.S. Patent and Trademark Office (USPTO). Patent status reports on chemical compounds. 2022.
